RadNet, Inc. Stock Issued During Period, Value, Restricted Stock Award, Forfeitures
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RadNet, Inc. stock issued during period, value, restricted stock award, forfeitures for the quarter ending 2026-06-30 was $18.00K, a 10.00% decline year-over-year.
- RadNet, Inc. stock issued during period, value, restricted stock award, forfeitures for the quarter ending 2026-03-31 was $65.00K, a 225.00% increase year-over-year.
- RadNet, Inc. stock issued during period, value, restricted stock award, forfeitures for the quarter ending 2025-12-31 was $43.00K, a 62.61% decline year-over-year.
- RadNet, Inc. stock issued during period, value, restricted stock award, forfeitures for the quarter ending 2025-09-30 was $150.00K, a 3650.00% increase year-over-year.
- RadNet, Inc. stock issued during period, value, restricted stock award, forfeitures for fiscal 2025 was $233.00K, a 52.29% increase from fiscal 2024.
- RadNet, Inc. stock issued during period, value, restricted stock award, forfeitures for fiscal 2024 was $153.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures 3 month | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures 12 month |
|---|---|---|
| 2026-06-30 | $18.00K 10-Q · filed 2026-08-10 | $276.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $65.00K 10-Q · filed 2026-05-11 | $278.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $233.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $150.00K 10-Q · filed 2025-11-10 | $305.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $20.00K 10-Q · filed 2026-08-10 | $159.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $20.00K 10-Q · filed 2026-05-11 | $164.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $153.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $4.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $25.00K 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $9.00K 10-Q · filed 2024-05-10 | |
| 2022-09-30 | $45.00K 10-Q · filed 2023-11-09 | |
| 2021-09-30 | $42.00K 10-Q · filed 2021-11-09 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | |
| 2019-06-30 | $5.00K 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |